E-LIB Suche - Ergebnisse für: Infante, Jeffrey R

1

Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of..:

Saleh, Mansoor N. ; Patel, Manish R. ; Bauer, Todd M....
Clinical Cancer Research. 28 (2022) 2 - p. 429-429 , 2022

Link: https://doi.org/10.1158/..

2

Translational Modeling Predicts Efficacious Therapeutic Dos..:

Girgis, Suzette ; Lin, Shun Xin Wang ; Pillarisetti, Kodandaram...
Targeted Oncology. 17 (2022) 4 - p. 433-439 , 2022

Link: https://doi.org/10.1007/..

3

Correction: Translational Modeling Predicts Efficacious The..:

Girgis, Suzette ; Lin, Shun Xin Wang ; Pillarisetti, Kodandaram...
Targeted Oncology. 17 (2022) 5 - p. 609-609 , 2022

Link: https://doi.org/10.1007/..

4

Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MD..:

Saleh, Mansoor N. ; Patel, Manish R. ; Bauer, Todd M....
Clinical Cancer Research. 27 (2021) 19 - p. 5236-5247 , 2021

Link: https://doi.org/10.1158/..

5

Safety and preliminary immunogenicity of JNJ-64041809, a li..:

Drake, Charles G. ; Pachynski, Russell K. ; Subudhi, Sumit K....
Prostate Cancer and Prostatic Diseases. 25 (2021) 2 - p. 219-228 , 2021

Link: https://doi.org/10.1038/..

6

A Phase I Dose-Escalation and Expansion Study of Telaglenas..:

Harding, James J. ; Telli, Melinda ; Munster, Pamela...
Clinical Cancer Research. 27 (2021) 18 - p. 4994-5003 , 2021

Link: https://doi.org/10.1158/..

7

Immunologic and tumor responses of pegilodecakin with 5-FU/..:

Hecht, J. Randolph ; Papadopoulos, Kyriakos P. ; Falchook, Gerald S....
Investigational New Drugs. 39 (2020) 1 - p. 182-192 , 2020

Link: https://doi.org/10.1007/..

8

Avelumab as second-line therapy for metastatic, platinum-tr..:

Apolo, Andrea B ; Ellerton, John A ; Infante, Jeffrey R...
Journal for ImmunoTherapy of Cancer. 8 (2020) 2 - p. e001246 , 2020

Link: https://doi.org/10.1136/..

9

A phase 2 study of glembatumumab vedotin, an antibody‐drug ..:

Ott, Patrick A. ; Pavlick, Anna C. ; Johnson, Douglas B....
Cancer. 125 (2019) 7 - p. 1113-1123 , 2019

Link: https://doi.org/10.1002/..

10

Phase I study of the anti-endothelin B receptor antibody-dr..:

Sandhu, Shahneen ; McNeil, Catriona M. ; LoRusso, Patricia...
Investigational New Drugs. 38 (2019) 3 - p. 844-854 , 2019

Link: https://doi.org/10.1007/..

11

A phase I, open-label, two-stage study to investigate the s..:

Aghajanian, Carol ; Bell-McGuinn, Katherine M. ; Burris III, Howard A....
Investigational New Drugs. 36 (2018) 6 - p. 1016-1025 , 2018

Link: https://doi.org/10.1007/..

12

Evaluation of the effect of dabrafenib and metabolites on Q..:

Nebot, Noelia ; Arkenau, Hendrik‐Tobias ; Infante, Jeffrey R....
British Journal of Clinical Pharmacology. 84 (2018) 4 - p. 764-775 , 2018

Link: https://doi.org/10.1111/..

13

Safety profile of avelumab in patients with advanced solid ..:

Kelly, Karen ; Infante, Jeffrey R. ; Taylor, Matthew H....
Cancer. 124 (2018) 9 - p. 2010-2017 , 2018

Link: https://doi.org/10.1002/..

14

Erratum: Phase 1 trials of PEGylated recombinant human hyal..:

Infante, Jeffrey R ; Korn, Ronald L ; Rosen, Lee S...
British Journal of Cancer. 118 (2018) 2 - p. e3-e3 , 2018

Link: https://doi.org/10.1038/..

15

A phase I dose-escalation study of selumetinib in combinati..:

LoRusso, Patricia M. ; Infante, Jeffrey R. ; Kim, Kevin B....
BMC Cancer. 17 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..